Collard, L., Moochhala, S. H., Gould, E., Boussetta, A., Fraga Rodriguez, G. M., ABROUG, S., & Ariceta Iraola, G. (2023). ePHex: A phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Citación estilo ChicagoCollard, Laure, Shabbir H. Moochhala, Edward Gould, Abir Boussetta, Gloria Mª Fraga Rodriguez, Saoussen ABROUG, y Gema Ariceta Iraola. EPHex: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Evaluate Long-term Efficacy and Safety of Oxalobacter Formigenes in Patients With Primary Hyperoxaluria. 2023.
Cita MLACollard, Laure, et al. EPHex: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Evaluate Long-term Efficacy and Safety of Oxalobacter Formigenes in Patients With Primary Hyperoxaluria. 2023.